The role of the microbiome in health and human disease has emerged at the forefront of medicine in the 21st century. Over the last 2 decades evidence has emerged to suggest that inflammation-derived oxidative damage and cytokine induced toxicity may play a significant role in the neuronal damage associated with Parkinson's disease (PD). Presence of pro-inflammatory cytokines and T cell infiltration has been observed in the brain parenchyma of patients with PD. Furthermore, evidence for inflammatory changes has been reported in the enteric nervous system, the vagus nerve branches and glial cells. The presence of α-synuclein deposits in the post-mortem brain biopsy in patients with PD has further substantiated the role of inflammation in PD. It has been suggested that the α-synuclein misfolding might begin in the gut and spread "prion like" via the vagus nerve into lower brainstem and ultimately to the midbrain; this is known as the Braak hypothesis. It is noteworthy that the presence of gastrointestinal symptoms (constipation, dysphagia, and hypersalivation), altered gut microbiota and leaky gut have been observed in PD patients several years prior to the clinical onset of the disease. These clinical observations have been supported by in vitro studies in mice as well, demonstrating the role of genetic (α-synuclein overexpression) and environmental (gut dysbiosis) factors in the pathogenesis of PD. The restoration of the gut microbiome in patients with PD may alter the clinical progression of PD and this alteration can be accomplished by carefully designed studies using customized probiotics and fecal microbiota transplantation.
Keywords: Dysbiosis; Fecal microbiota transplantation; Microbiota; Parkinson disease; Probiotics.
Conflict of interest statement
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.Int J Mol Sci. 2018 Jun 6;19(6):1689. doi: 10.3390/ijms19061689. Int J Mol Sci. 2018. PMID: 29882798 Free PMC article. Review.
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.Ageing Res Rev. 2018 Aug;45:53-61. doi: 10.1016/j.arr.2018.04.004. Epub 2018 Apr 26. Ageing Res Rev. 2018. PMID: 29705121 Review.
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.Brain Behav Immun. 2018 May;70:48-60. doi: 10.1016/j.bbi.2018.02.005. Epub 2018 Feb 20. Brain Behav Immun. 2018. PMID: 29471030
Brain-gut-microbiota axis in Parkinson's disease.World J Gastroenterol. 2015 Oct 7;21(37):10609-20. doi: 10.3748/wjg.v21.i37.10609. World J Gastroenterol. 2015. PMID: 26457021 Free PMC article. Review.
Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.Neurochem Res. 2018 Oct;43(10):1986-1999. doi: 10.1007/s11064-018-2620-x. Epub 2018 Aug 31. Neurochem Res. 2018. PMID: 30171422
Cited by 3 articles
Minireview on the Relations between Gut Microflora and Parkinson's Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities.Oxid Med Cell Longev. 2020 Feb 5;2020:4518023. doi: 10.1155/2020/4518023. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32089768 Free PMC article. Review.
The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model.Cell Transplant. 2019 Dec;28(1_suppl):87S-99S. doi: 10.1177/0963689719891134. Epub 2019 Nov 28. Cell Transplant. 2019. PMID: 31775521 Free PMC article.
Probiotics for Parkinson's Disease.Int J Mol Sci. 2019 Aug 23;20(17):4121. doi: 10.3390/ijms20174121. Int J Mol Sci. 2019. PMID: 31450864 Free PMC article. Review.